Target
Kallikrein-1
Ligand
BDBM50031706
Substrate
n/a
Meas. Tech.
ChEMBL_92381 (CHEMBL701594)
IC50
34100±n/a nM
Citation
 Senokuchi, KNakai, HNakayama, YOdagaki, YSakaki, KKato, MMaruyama, TMiyazaki, TIto, HKamiyasu, K New orally active serine protease inhibitors. J Med Chem 38:2521-3 (1995) [PubMed]
Target
Name:
Kallikrein-1
Synonyms:
KLK1 | KLK1_HUMAN | Kallikrein 1 | Kallikrein-1 | Kidney/pancreas/salivary gland kallikrein | Tissue kallikrein
Type:
Enzyme
Mol. Mass.:
28874.69
Organism:
Homo sapiens (Human)
Description:
P06870
Residue:
262
Sequence:
MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS
  
Inhibitor
Name:
BDBM50031706
Synonyms:
4-Guanidino-benzoic acid 4-dimethylcarbamoylmethoxycarbonylmethyl-phenyl ester; compound with methanesulfonic acid | CHEMBL85164 | Camostat | med.21724, Compound 18
Type:
Small organic molecule
Emp. Form.:
C20H22N4O5
Mol. Mass.:
398.4125
SMILES:
[#6]-[#7](-[#6])-[#6](=O)-[#6]-[#8]-[#6](=O)-[#6]-c1ccc(-[#8]-[#6](=O)-c2ccc(cc2)\[#7]=[#6](/[#7])-[#7])cc1
Structure:
Search PDB for entries with ligand similarity: